Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

SCHEDULE OF GRANTED OPTIONS (Details)

v3.25.1
SCHEDULE OF GRANTED OPTIONS (Details) - Employees [Member]
12 Months Ended
Dec. 31, 2024
£ / shares
shares
Number of shares options outstanding, beginning | shares 27
Weighted average exercise price outstanding, beginning | £ / shares £ 92,000
Number of shares options, Exercised | shares
Weighted average exercise price outstanding, Exercised | £ / shares
Number of shares options outstanding, ending | shares 27
Weighted average exercise price outstanding, ending | £ / shares £ 92,000
Number of shares options exercisable, ending | shares 27
Weighted average exercise price exercisable, ending | £ / shares £ 92,000
Number of shares options unexercisable, ending | shares
Weighted average exercise price unexercisable, ending | £ / shares